Cannabis prescribing guidelines spark concern

Australia’s first cannabis prescribing guidelines have been described as mysterious, unjustified, and not supported by evidence.

The 29-page document from the Queensland health department, made public on Australia Day, provides guidance on sourcing, doses and regimens.

The guidelines focus on treatment of drug-resistant epilepsy in children, and symptom control in palliative care, chemotherapy and multiple sclerosis.

Yet a puzzled Dr Evan Ackermann, chair of the RACGP’s Expert Committee on Quality Care, says they have “no justification in evidence”.